Clinical Trial Update: Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nivolumab, cabiralizumab, and gemcitabine in patients with stage IV pancreatic cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cabiralizumab
• Gemzar (gemcitabine)
• nivolumab (nivolumab)

Snippet

Sponsor: Hitendra Patel | Conditions: Pancreatic Cancer Stage IV | Phase 2 | Status: COMPLETED | Results posted: 2025-08-06